Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Vor Biopharma Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 69 | 71 | +2 |
| Shares | 58.9M | 54.5M | −4.42M (−7.5%) |
| Value | $139.7M | $54.5M | −$85.2M (−61.0%) |
New holders (23)
Institutions that held Vor Biopharma Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (21)
Institutions that held Vor Biopharma Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Woodline Partners LP | 1,111,123 | $2.63M |
| Artal Group S.A. | 1,000,000 | $2.37M |
| Bank of New York Mellon Corp | 104,551 | $247.8K |
| Nuveen Asset Management, LLC | 71,504 | $169.5K |
| Deutsche Bank AG | 31,835 | $75.4K |
| Bourgeon Capital Management LLC | 29,450 | $69.8K |
| American International Group, Inc. | 18,809 | $44.6K |
| XTX Topco Ltd | 18,645 | $44.2K |
| Invesco Ltd. | 17,382 | $41.2K |
| Walleye Capital LLC | 16,550 | $39.2K |
| Voya Investment Management LLC | 14,667 | $34.8K |
| Wells Fargo & Company | 13,489 | $32.0K |
| SG Americas Securities, LLC | 13,182 | $31.0K |
| California State Teachers Retirement System | 3,837 | $9.09K |
| Legal & General Group Plc | 3,627 | $8.60K |
| Ameritas Investment Partners, Inc. | 3,111 | $7.37K |
| Comerica Bank | 2,661 | $6.31K |
| Amalgamated Bank | 1,270 | $3.00K |
| Royal Bank of Canada | 870 | $2.00K |
| Nisa Investment Advisors, LLC | 45 | $107 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 6 | $14 |